PIPr Therapeutics
PrivateLast Round
Series A
Extension
Mar 1, 2021
Total Funding Raised
$23M
Company Overview
PIPr Therapeutics is a biotechnology company that develops small molecule inhibitors targeting metalloproteases for the treatment of inflammatory and immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PIPr Therapeutics Comparables
Compare PIPr Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Piton Therapeutics | 80% | |
| Symberix, Inc. | 80% | |
| Giiant Pharma Inc. | 76% |
PIPr Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 1, 2021 | ||||
| Series A | Jun 10, 2019 |
PIPr Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Series A Extension |
| Hatteras Venture Partners | Series A, Series A Extension |
| Osage University Partners | Series A, Series A Extension |
| Elm Street Ventures | Series A, Series A Extension |
| Johnson & Johnson Innovation – JJDC | Series A |
| Malin PLC | Series A |
PIPr Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PIPr Therapeutics's valuation, stock price, and market status.
Is PIPr Therapeutics a public or private company?
PIPr Therapeutics is a private company.
What is the current stock price of PIPr Therapeutics?
PIPr Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is PIPr Therapeutics worth (valuation)?
Valuation information for PIPr Therapeutics is not publicly available.
Can I buy PIPr Therapeutics stock?
PIPr Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PIPr Therapeutics's last funding round?
PIPr Therapeutics's most recent funding round was Series A Extension on March 1, 2021.
Who are the main investors in PIPr Therapeutics?
Key investors in PIPr Therapeutics include Hatteras Venture Partners.
Will PIPr Therapeutics IPO soon?
No public IPO plans have been announced for PIPr Therapeutics.
How can I track PIPr Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PIPr Therapeutics's secondary market activity and sign up for updates.